Lifefactors Zona Franca, SAS

Quick facts

Phase 2 pipeline

• Anti-COVID-19 human immunoglobulin · Infectious Diseases
  Anti-COVID-19 human immunoglobulin works by providing pre-formed antibodies to neutralize the SARS-CoV-2 virus.
• COVID-19 convalescent plasma · Infectious Diseases
  COVID-19 convalescent plasma is a treatment that uses antibodies from recovered patients to help the body fight off the SARS-CoV-2 virus.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Lifefactors Zona Franca, SAS portfolio CI brief
• Lifefactors Zona Franca, SAS pipeline updates RSS